; ContraFect Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

ContraFect Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VIEWS: 0 PAGES: 19

ContraFect Corporation (ContraFect) is a biotechnology company. It undertakes the research, development and commercialization of pharmaceutical drugs for the treatment of infections due to drug resistant staphylococcus, influenza and gram-positive bacteria. The company develops these drugs based on its proprietary technologies that include Lysin therapy, Synbiotic therapy, Single MAB (monoclonal antibodies) therapy to conserved targets, and MAB combination therapy.

More Info
  • pg 1
									                             ContraFect Corporation - Pharmaceuticals & Healthcare - Deals and
                                                      Alliances Profile
       Reference Code: GDPH274012D                                                                                                              Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      ContraFect Corporation (ContraFect) is a biotechnology company. It undertakes the
                                                                                                              ContraFect Corporation, Pharmaceuticals &
      research, development and commercialization of pharmaceutical drugs for the
                                                                                                              Healthcare, Key Facts
      treatment of infections due to drug resistant staphylococcus, influenza and gram-
      positive bacteria. The company develops these drugs based on its proprietary                             Web Address                            www.contrafect.com
      technologies that include Lysin therapy, Synbiotic therapy, Single MAB (monoclonal
                                                                                                               Revenue (US$ million)                                 NA
      antibodies) therapy to conserved targets, and MAB combination therapy.
                                                                                                               Number of Employees                                   NA
                                                                                                               GlobalData

      Financial Deals Landscape
        ContraFect Corporation, Pharmaceuticals & Healthcare, Deals by                    ContraFect Corporation, Pharmaceuticals & Healthcare,
        Type, 2007 to YTD 2013                                                            Deals By Year, 2007 to YTD 2013

                                                                                                          5
                                                                                                                                            4
                                                                                                          4


                                                                                           No. of Deals
                                                                                                                                                      3
                                                                                                          3

                                                                                                          2

                                                                                                          1
                                                                                                                 0         0       0                       0          0
                                                                                                          0
                                                                                                               2007       2008   2009      2010   2011    2012       YTD
                                                                                                                                                                     2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from        from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         ContraFect Corporation, Pharmaceuticals & Healthcare,                            ContraFect Corporation, Pharmaceuticals & Healthcare,
         Deals By Region, 2007 to YTD 2013                                                Deals By Therapy Area, 2007 to YTD 2013

                         8        7                                                                       8           7
          No. of Deals




                                                                                           No. of Deals




                         6                                                                                6

                         4                                                                                4

                         2                 1                                                              2
                                                    0         0        0                                                               0          0              0
                         0                                                                                0
                                North    Europe    Asia-    Middle   South                                       Infectiou       Cardiova       Central   Pharmac
                                Americ            Pacific    East     and                                        s Disease        scular        Nervous    euticals
                                  a                          and     Central                                                                    System       and
                                                            Africa   Americ                                                                               Healthcar
                                                                       a                                                                                      e



         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




ContraFect Corporation - Pharmaceuticals & Healthcare - Deals                                                                                     Reference Code: GDPH274012D
and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                   Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       ContraFect Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ............................................................ 3
       ContraFect Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ............................................................. 5
       ContraFect Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 ........................................................ 6
       ContraFect Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 .............................................. 7
       ContraFect Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013.......................................................... 8
       ContraFect Corporation, Pharmaceuticals & Healthcare, Deal Details............................................................................................... 9
          Venture Financing........................................................................................................................................................................... 9
             ContraFect Secures $12.5 Million In Venture Financing ............................................................................................................. 9
             ContraFect Secures $2.2 Million In Series A Financing ............................................................................................................ 10
             ContraFect Secures $12 Million In Series B Financing ............................................................................................................. 11
             ContraFect Secures $4 Million In Venture Financing ................................................................................................................ 12
          Licensing Agreements .................................................................................................................................................................. 13
             ContraFect Enters Into Licensing Agreement With Rockefeller University ................................................................................ 13
             MorphoSys Enters Into Licensing Agreement With ContraFect ................................................................................................ 14
             ContraFect Enters Into Licensing Agreement With Rockefeller University ................................................................................ 15
       ContraFect Corporation - Key Competitors ...................................................................................................................................... 16
       Key Employees .........................................................................................................................
								
To top
;